空气污染阻碍了使用核酸/核酸类似物治疗的慢性乙型肝炎患者的ALT正常化
Tyng-Yuan Jang1,2,3, Chi-Chang Ho4, Chih-Da Wu5,6
1Ph.D. Program in Environmental and Occupational Medicine, College of Medicine, Kaohsiung Medical University and National Health Research Institutes, Kaohsiung, Taiwan.
Medicine
|October 31, 2023
概括
核酸/核酸模拟疗法改善了慢性乙型肝炎 (CHB) 患者的阿氨酸转移酶 (ALT) 正常化. 然而,空气污染,特别是臭氧,独立地影响ALT正常化成功.
科学领域:
- 肝病学和病毒性胃肠道学
- 环境健康和毒理学
- 生物化学和临床诊断学
背景情况:
- 氨酸氨基转移酶 (ALT) 的正常化是接受核酸/核酸模拟剂 (NA) 治疗的慢性乙型肝炎 (CHB) 患者的关键预后指标.
- 环境空气污染物对CHB患者ALT正常化的影响仍然在很大程度上未被探索.
研究的目的:
- 研究空气污染对接受NA治疗的B型肝炎e抗原阴性CHB患者ALT正常化的影响.
- 为了确定与ALT异常相关的风险因素,尽管NA治疗.
主要方法:
- 一项纵向研究涉及80名B型肝炎e抗原阴性CHB患者,接受NAs治疗.
- 在基线和治疗1年后测量ALT水平.
- 与空气污染物的汇总月度数据进行相关性分析,包括PM2.5,二氧化,臭氧 (O3) 和.
主要成果:
- 在NA治疗1年后,93.8%的患者达到无法检测的乙型肝炎病毒DNA水平,平均ALT水平显著降低 (30.0至21.3U/L).
- 患有正常ALT水平的患者比例显著增加,从51.2%增加到71.2%.
- 较高的体重指数 (OR,1.28) 和增加的臭氧水平 (OR,1.11) 独立地与治疗1年后异常的ALT水平相关.
结论:
- 一年NA治疗有效改善ALT水平,并增加低病毒载荷的CHB患者的正常化率.
- 空气污染,特别是臭氧,构成了重大环境挑战,影响了CHB患者ALT正常化疗法的有效性.
- 增加的BMI和暴露于臭氧是管理CHB患者ALT正常化时需要考虑的关键因素.
更多相关视频
06:12Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
11.4K
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
相关概念视频
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
